Sudan vs United States: The number of people with susceptibility test result for rifampicin
Sudan
6,193
in 2021
United States
4,814
in 2021
Sudan rank
27th
United States rank
30th
The number of people with susceptibility test result for rifampicin over time
- Sudan
- United States
How they compare
Sudan currently reports 6,193 against 4,814 in United States, a difference of 1,379.
That makes Sudan's figure about 1.3 times United States's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was United States ahead.
Sudan ranks 27th and United States ranks 30th of 155 countries.
Across the 2 decades both report, Sudan averaged higher in 1 and United States in 1.
Head to head by decade
| Decade | Sudan | United States | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1,894 | 5,218 | 3,324 | United States |
| 2020s | 5,498 | 4,592 | 906.5 | Sudan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Sudan or United States?
- Sudan, at 6,193 against 4,814 in United States as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Sudan and United States?
- 1,379, with Sudan ahead.
- How many years of comparable data are there for Sudan and United States?
- 5 years are reported by both, from 2017 to 2021.
- How do Sudan and United States rank globally for the number of people with susceptibility test result for rifampicin?
- Sudan ranks 27th and United States ranks 30th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.